These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. [Enteropathy associated with chronic use of olmesartan]. Téllez A; Pellicé M; Llobell A; Milisenda JC Med Clin (Barc); 2015 Feb; 144(3):139-40. PubMed ID: 24930862 [No Abstract] [Full Text] [Related]
16. Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report. Makri A; Florentin M; Elisaf MS; Liamis G Curr Drug Saf; 2019; 14(3):238-241. PubMed ID: 30848210 [TBL] [Abstract][Full Text] [Related]
17. A Case of Olmesartan-associated Sprue-like Enteropathy. Nagashima K; Katsurada T; Sakamoto N Clin Gastroenterol Hepatol; 2018 Oct; 16(10):A45-A46. PubMed ID: 29247793 [No Abstract] [Full Text] [Related]
18. [Olmesartan-associated enteropathy: attention to an emerging iatrogenic phenomenon]. Modesto Dos Santos JL; González Recio P; Terry López OA; Leturia Frade I; Aguiar Losada B; Elejalde Guerra JI An Sist Sanit Navar; 2017 Aug; 40(2):291-294. PubMed ID: 28676728 [TBL] [Abstract][Full Text] [Related]
19. Acute kidney injury secondary to diarrhea caused by "sprue-like" enteropathy associated with olmesartan. Roca-Argente L; Diaz-Jaime FC; López-Romero LC; Manzur-Aguilar Y; Moll-Guillem JL; Del Val-Antoñana A; Hernandez-Jaras J Nefrologia; 2017; 37(5):548-550. PubMed ID: 28027786 [No Abstract] [Full Text] [Related]